CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.
about
The impact of the Cancer Genome Atlas on lung cancer.CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation.ConGEMs: Condensed Gene Co-Expression Module Discovery Through Rule-Based Clustering and Its Application to Carcinogenesis.CLCA2 is a positive regulator of store-operated calcium entry and TMEM16A.
P2860
CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@ast
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@en
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@nl
type
label
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@ast
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@en
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@nl
prefLabel
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@ast
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@en
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@nl
P2093
P2860
P50
P356
P1433
P1476
CLCA2 as a novel immunohistoch ...... om adenocarcinoma of the lung.
@en
P2093
Akikazu Kawase
Hiroshi Ogawa
Hisaki Igarashi
Hisami Kato
Kazuhito Funai
Satoki Nakamura
Yuichi Kawanishi
Yusuke Inoue
P2860
P304
P356
10.1155/2014/619273
P577
2014-12-07T00:00:00Z